(s, 2H, OCH2O), 6.65 (d, 1H, J 7.9 Hz, ArH), 6.69 (s, 1H, ArH),
6.77 ppm (d, 1H, J 7.9 Hz, ArH). 13C NMR (100 MHz, CDCl3): δ
29.1, 50.6, 101.1, 108.5, 109.8, 122.5, 127.8, 146.7, 147.9, 206.5 ppm.
Reductive Amination of PMK. Al/Hg Amalgam (Route 1).27
To aluminum foil (4.5 g) cut into 2 cm squares was added water
(159 mL) containing mercuric chloride (0.11 g, 0.41 mmol, 1.2
mol %). The amalgamation was allowed to proceed with swirling
for 3 min, and fine bubbles and a light gray precipitate were
observed. The water was decanted and the foil washed with fresh
water (317 mL). The water from the last wash was removed from
the foil as thoroughly as possible by shaking. Added to the
remaining foil in succession were methylamine hydrochloride (6.8
g, 100 mmol, 3 equiv) dissolved in water (6.8 mL), isopropyl
alcohol (20 mL), 25% aqueous NaOH (16 mL, 588 mmol), PMK
(6 g, 33 mmol), and isopropyl alcohol (39 mL). The mixture was
immersed in an ice bath as necessary to keep the temperature
below 50 °C. Once thermally stable, the mixture was left stirring
overnight. The resultant mixture was then filtered through celite,
rinsing with methanol, and the volatiles removed in vacuo. The
residue was suspended in water (272 mL), and 32% aqueous
hydrochloric acid added to make the phase acidic (pH 1). Excess
PMK was extracted with DCM (3 × 75 mL). The remaining
aqueous layer was made basic (pH 9) with 25% aqueous NaOH
and extracted with DCM (3 × 75 mL). A further 10 drops of 25%
aqueous NaOH were added before the second and third DCM
extractions, respectively. The combined organic layers were dried
over magnesium sulfate and the solvent removed in vacuo to
reveal MDMA base as an amber oil (4.2 g, 65% yield). Analysis
NaBH4 (Route 2).2 To a well stirred solution of methylamine
hydrochloride (3 g, 44 mmol, 1.7 eq) in methanol (25 mL) at -20
°C was added a solution of solid sodium hydroxide (1.8 g, 45
mmol, 1.7 equiv) dissolved in methanol (35 mL). Addition was
portionwise so as to keep the temperature of the solution at -20
°C in an acetone bath containing chips of dry ice. PMK (4.6 g, 25
mmol) was then added and the mixture allowed to warm to 0 °C.
Stirring was continued for 1 h. To the solution was added sodium
borohydride (0.46 g, 12 mmol), portionwise, so as to keep the
temperature at 0 °C. The mixture was stirred overnight at 5 °C in
a cryogenic bath. Methanol was removed in vacuo and the residue
dissolved in water (330 mL). The mixture was acidified with 32%
aqueous HCl (pH 1) and extracted with DCM (3 × 75 mL) to
remove excess PMK. The aqueous phase was basified with 25%
aqueous NaOH (pH 11) and the organics extracted with DCM (3
× 75 mL). A further 20 drops of 25% aqueous NaOH were added
before the second and third DCM extractions, respectively. The
combined organic layers were dried over MgSO4 and concen-
trated, resulting in clean MDMA (3.4 g, 68% yield). The MDMA
base was converted to the HCl salt according to the procedure
detailed above. Analyses were as described previously.
Pt/H2 (Route 3).35 To ethanol (5 mL) was added a solution of
40% methylamine in water (2 mL, 58 mmol, 4.4 equiv). PMK (2
mL, 13 mmol) was slowly added to the mixture and allowed to
stir at room temperature for 1 h. To the mixture was added PtO2
(0.05 g, 0.2 mmol, 1.7 mol %) under a stream of nitrogen. The
resultant mixture was placed under a hydrogen atmosphere at
56 psi for 3.5 h. The pressure in the device was returned to 56
psi at the 1 and 2 h marks. After filtration through celite with
ethanol to remove PtO2, the volatiles were removed in vacuo. The
residue was dissolved in water (165 mL) and acidified with 32%
aqueous HCl (pH 1) and extracted with DCM (3 × 75 mL). The
aqueous phase was basified with 25% aqueous NaOH (pH 10) and
the organics extracted with DCM (3 × 75 mL). A further 10 and
20 drops of 25% aqueous NaOH were added before the second
and third DCM extractions, respectively. The combined organic
layers were dried over MgSO4 and concentrated to give clean
MDMA as an amber oil (2.0 g, 78% yield). The MDMA base was
converted into its HCl salt according to the procedure above.
Analyses were as described previously.
was in agreement with published data.31,32 IR vmax (CH2Cl2)/cm-1
:
1
1489, 1444, 1249 (C-O), 1041 (C-O), 938. H NMR (400 MHz,
CDCl3): δ 1.05 (d, 3H, J 6.2 Hz, CH3), 2.40 (s, 3H, NCH3), 2.52 -
2.65 (m, 2H, CH2), 2.69 - 2.77 (m, 1H, CH), 5.93 (s, 2H, OCH2O),
6.63 (dd, 1H, J 7.8 and 1.4 Hz, ArH), 6.68 (d, 1H J 1.5 Hz, ArH),
6.73 ppm (d, 1H, J 7.8 Hz, ArH). 13C NMR (100 MHz, CDCl3): δ
19.9, 34.2, 43.4, 56.7, 101.0, 108.4, 109.7, 122.4, 133.5, 146.1, 147.9
ppm.
Conversion of MDMA base to the HCl salt was achieved by
dissolving the base (1.5 g, 7.7 mmol) in isopropyl alcohol (2.5
mL) and acidifying with 37% aqueous HCl (30 drops). The solvent
was removed in vacuo with heat to reveal a precipitate (ranging
in color from white to pink to brown) which was homogenized
and washed with a 2:1 isopropyl alcohol:ether solution before a
final wash with ether. The resulting white MDMA hydrochloride
was dried under high vacuum (1.7 g, 95% yield). Analysis was in
agreement with published data.31,33,34 IR vmax (CH2Cl2)/cm-1: 1491,
Stable Isotope Analysis by Isotope Ratio Mass Spectrom-
etry. 13C and 15N Isotope Analysis by EA-IRMS: Carbon and
nitrogen isotope abundance analyses were carried out using an
automated nitrogen-carbon analyzer (ANCA) coupled to an
automated breath carbon analyzer (ABCA) isotope ratio mass
spectrometer (SerCon Ltd, Crewe, U.K.). Typically 0.4 mg of
sample material was weighed into tin capsules (Elemental Mi-
croanalysis, Devon, U.K.) and introduced via a solid Costech Zero-
Blank autosampler (Pelican Scientific Ltd, Alford, U.K.). The
Elemental Analyzer (EA) reactor tubes were comprised of two
quartz glass tubes filled with chromium(III) oxide / copper oxide
and reduced copper, held at 1020 °C and 620 °C for combustion
and reduction, respectively. A water trap filled with magnesium
perchlorate was used to remove water from combustion gases
thus generated, and a postreactor GC column was kept at 65 °C
1
1447, 1246 (C-O), 1040 (C-O), 932. H NMR (400 MHz, D2O):
δ 1.32 (d, 3H, J 6.6 Hz, CH3), 2.74 (s, 3H, NCH3), 2.85-2.91 (m,
1H, CH2) 3.00-3.05 (m, 1H, CH2), 3.53 (m, 1H, CH), 6.01 (s, 2H,
OCH2O), 6.83 (dd, 1H, J 7.9 and 1.4 Hz, ArH), 6.89 (d, 1H, J 1.4
Hz, ArH), 6.93 ppm (d, 1H, J 8.0 Hz, ArH). 13C NMR (100 MHz,
D2O): δ 15.4, 30.5, 39.0, 57.1, 101.7, 109.3, 110.3, 123.4, 130.3,
147.0, 148.4 ppm.
(31) Dal Cason, T. A. J. Forensic Sci. 1989, 34, 928-961.
(32) Dal Cason, T. A.; Meyers, J. A.; Lankin, D. C. Forensic Sci. Int. 1997, 86,
15-24.
(33) Bailey, K.; By, A. W.; Legault, D.; Verner, D. J. Assoc. Off. Anal. Chem. 1975,
58, 62-69.
(34) Lee, G. S. H.; Craig, D. C.; Kannangara, G. S. K.; Dawson, M.; Conn, C.;
Robertson, J.; Wilson, M. A. J. Forensic Sci. 1999, 44, 761-771.
(35) Uncle Fester. Secrets of Methamphetamine Manufacture: Including Recipes
for MDA, Ecstasy, & Other Psychedelic Amphetamines, 5th ed.; Loompanics
Unlimited: Port Townsend: Washington, 1999.
3352 Analytical Chemistry, Vol. 80, No. 9, May 1, 2008